A shortcut to testing for Ebola

July 4, 2018 by Shaun Cowe, Particle

Viruses and poverty seem to go hand in hand, as we saw with the West African Ebola virus epidemic. But one researcher is fighting back by developing a testing kit that can tackle Ebola, even in the world's poorest places.

Viruses are an inescapable part of human existence—from the mild inconvenience of the common cold to society-crushing pandemics. Viruses' ability to evolve and adapt to overcome our best defences makes them dangerous foes to humanity. When a particularly deadly grows in a world region without access to high-quality healthcare, the results can be disastrous.

Ameh James, a Ph.D. researcher in molecular biology from USC, is fighting the resurgence of one of the most deadly viruses in recent years, Ebola. To do this, he has developed a test that can detect the earliest stages of Ebola virus in just 30 minutes.

"It started in 2015 when I first arrived in Australia on my Ph.D. scholarship. I remember coming home after a day's work in the lab. I turned on the news, and Ebola virus was killing a lot of people in Africa. It was spreading to other countries. Everybody was scared," Ameh says.

"I asked myself how I could contribute. That's when I thought of developing a simple Ebola ."

Breaking down Ebola tests

A common way to test for viruses is to look for antigens.

Antigens are proteins on the surface of a viral cell that our antibodies use to find and kill the virus. Basically, the antigen is the target for the immune system to seek and destroy. It's also the target for many of our current Ebola tests.

But early detection is a problem in antigen tests. Most tests work by changing colour in the presence of Ebola antigens reacting with our antibodies. However, if the virus hasn't spread enough within a person, the reaction won't be big enough for the detector.

Beating the system

Another problem is a virus's antigens change form as it evolves. This allows Ebola to hide from our antibodies and our tests. Viruses can evolve very quickly, so virus tests that use these antigen markers must be constantly updated.

Ameh wanted to create an Ebola test that would continue to find new strains of Ebola as the virus evolved.

To do this, Ameh tested the Ebola virus's ribonucleic acid strand (RNA). RNA takes a similar role in viruses to its bigger brother, DNA. Ebola's RNA strand carries the virus's genetic blueprint and infects our cells with it, turning them into factories for making more Ebola.

RNA testing catches Ebola earlier because the RNA collected from blood is amplified in a test tube for 30 minutes before testing. Because of this growth period, Ameh's test can detect Ebola at earlier stages than antigen detection tests such as ReEBOV and OraQuick.

By targeting Ebola's RNA strand, the test is future-proofed against new strains with different antigens. It also allows the disease to be detected much earlier. Ebola can kill over half those infected, so catching it early is critical to stopping the spread.

The survivability test

It's not just about early detection. In many of the poorest areas of West Africa, medical services are limited. Ameh's test is cheap, easy to use and requires only basic medical equipment. This makes it a powerful tool for combating Ebola in poverty-stricken areas.

"I worked in Africa for more than 10 years as a pathologist. Our labs don't have the resources we have here. There are issues with power and water supply, but also space. It's very difficult to have testing equipment and keep it running," Ameh says.

"Also, not many people are trained in lab practices. Sample contamination is a big problem. To stop this, I made my test easy. All you need to do is stick the sample into my testing kit and put it straight into a machine most labs already have."

The Ebola epidemic scared the world when discovered, but in places like Liberia and Guinea, it tore apart entire communities. Despite this tragedy, we're learning more about viral outbreaks and creating better defences for the future. With tests like those created by Ameh James, we're fighting back and saving lives.

Explore further: Researchers inhibit Ebola virus

Related Stories

Researchers inhibit Ebola virus

December 29, 2017
The incurable Ebola virus has long been feared due to its high mortality rate and danger of infection. Now researchers from the University of Copenhagen and Phillips Universität Marburg have succeeded in inhibiting the virus ...

Ebola virus exploits host enzyme for efficient entry to target cells

February 7, 2018
Researchers have identified a key process that enables the deadly Ebola virus to infect host cells, providing a novel target for developing antiviral drugs. The Ebola virus incorporates a cellular enzyme into its virus particles, ...

Super cell to contain deadly Ebola virus discovered in Australia

July 18, 2017
A super cell in the eye has been discovered that can stop the deadly Ebola virus.

UN: Latest Ebola outbreak in Guinea is now over

June 1, 2016
The World Health Organization says the latest Ebola outbreak in Guinea has ended and the country is now entering a 90-day heightened surveillance period to monitor for any unexpected cases.

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.